Nir Hacohen

Nir Hacohen, the esteemed Director of the Center for Cancer Research at MGH and a pioneer in immunology, dives into captivating topics. He discusses the surge in antibody therapies and the challenges of STING agonists, urging caution before mechanistic understanding. Nir emphasizes the need for personalized cancer vaccines and reveals intriguing findings about a unique immune cell linked to sepsis. He showcases how spatial biology within tumors impacts therapeutic responses and the importance of tailoring treatments to individual patient profiles.